RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila

Neuron

Volumn 39, Issue 5, 2003, Pages 739-747

  Jin, Peng ^a   Zarnescu, Daniela C ^a   Zhang, Fuping ^a   Pearson, Christopher E ^c   Lucchesi, John C ^b   Moses, Kevin ^a   Warren, Stephen T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; MUTANT PROTEIN; RNA; TRINUCLEOTIDE; UBIQUITIN;

ANIMAL TISSUE; ARTICLE; CELL INCLUSION; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; FRAGILE X SYNDROME; GENE DOSAGE; GENE MUTATION; GENE OVEREXPRESSION; MOLECULAR GENETICS; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

DROSOPHILA;

EID: 0041880131     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(03)00533-6     Document Type: Article

References (36)

1. Bonini N.M., Fortini M.E. Human neurodegenerative disease modeling using Drosophila. Annu. Rev. Neurosci. 26:2003;627-656.
2. Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 118:1993;401-415.
3. Chan H.Y., Warrick J.M., Gray-Board G.L., Paulson H.L., Bonini N.M. Mechanisms of chaperone suppression of polyglutamine disease. selectivity, synergy and modulation of protein solubility in Drosophila Hum. Mol. Genet. 9:2000;2811-2820.
4. Chan H.Y., Warrick J.M., Andriola I., Merry D., Bonini N.M. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11:2002;2895-2904.
5. Cummings C.J., Sun Y., Opal P., Antalffy B., Mestril R., Orr H.T., Dillmann W.H., Zoghbi H.Y. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10:2001;1511-1518.
6. Elefant F., Palter K.B. Tissue-specific expression of dominant negative mutant Drosophila HSC70 causes developmental defects and lethality. Mol. Biol. Cell. 10:1999;2101-2117.
7. Ellis M.C., O'Neill E.M., Rubin G.M. Expression of Drosophila glass protein and evidence for negative regulation of its activity in non-neuronal cells by another DNA-binding protein. Development. 119:1993;855-865.
8. Feng Y., Zhang F., Lokey L.K., Chastain J.L., Lakkis L., Eberhart D., Warren S.T. Translational suppression by trinucleotide repeat expansion at FMR1. Science. 268:1995;731-734.
9. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J.et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 408:2000;101-106.
10. Freeman M. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell. 87:1996;651-660.
11. Gabai V.L., Meriin A.B., Mosser D.D., Caron A.W., Rits S., Shifrin V.I., Sherman M.Y. Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J. Biol. Chem. 272:1997;18033-18037.
12. Greco C.M., Hagerman R.J., Tassone F., Chudley A.E., Del Bigio M.R., Jacquemont S., Leehey M., Hagerman P.J. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain. 125:2002;1760-1771.
13. Hagerman R.J., Hagerman P.J. The fragile X premutation. into the phenotypic fold Curr. Opin. Genet. Dev. 12:2002;278-283.
14. Hagerman R.J., Leehey M., Heinrichs W., Tassone F., Wilson R., Hills J., Grigsby J., Gage B., Hagerman P.J. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 57:2001;127-130.
15. Hsiung F., Moses K. Retinal development in Drosophila. specifying the first neuron Hum. Mol. Genet. 11:2002;1207-1214.
16. Ito K., Awano W., Suzuki K., Hiromi Y., Yamamoto D. The Drosophila mushroom body is a quadruple structure of clonal units each of which contains a virtually identical set of neurones and glial cells. Development. 124:1997;761-771.
17. Jacquemont S., Hagerman R.J., Leehey M., Grigsby J., Zhang L., Brunberg J.A., Greco C., Des Portes V., Jardini T., Levine R.et al. Fragile X premutation tremor/ataxia syndrome. molecular, clinical, and neuroimaging correlates Am. J. Hum. Genet. 72:2003;869-878.
18. Kazemi-Esfarjani P., Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science. 287:2000;1837-1840.
19. Kenneson A., Zhang F., Hagedorn C.H., Warren S.T. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet. 10:2001;1449-1454.
20. Kunst C.B., Warren S.T. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell. 77:1994;853-861.
21. Li H., Li S.H., Johnston H., Shelbourne P.F., Li X.J. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet. 25:2000;385-389.
22. Lin D.M., Goodman C.S. Ectopic and increased expression of Fasciclin II alters motoneuron growth cone guidance. Neuron. 13:1994;507-523.
23. Mosser D.D., Caron A.W., Bourget L., Meriin A.B., Sherman M.Y., Morimoto R.I., Massie B. The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol. Cell. Biol. 20:2000;7146-7159.
24. Muqit M.M., Feany M.B. Modelling neurodegenerative diseases in Drosophila. a fruitful approach? Nat. Rev. Neurosci. 3:2002;237-243.
25. O'Donnell W.T., Warren S.T. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25:2002;315-338.
26. Primerano B., Tassone F., Hagerman R.J., Hagerman P., Amaldi F., Bagni C. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA. 8:2002;1482-1488.
27. Ranum L.P., Day J.W. Dominantly inherited, non-coding microsatellite expansion disorders. Curr. Opin. Genet. Dev. 12:2002;266-271.
28. Rosser T.C., Johnson T.R., Warren S.T. A cerebellar FMR1 riboCGG binding protein. Am. J. Hum. Genet. 71:2002;507.
29. Sherman S.L. Epidemiology. Treatment and Research R.J., Hagerman and P.J., Hagerman Fragile X Syndrome. Diagnosis:2002;The Johns Hopkins University Press, Baltimore, MD. 136-168.pp.
30. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4:2003;49-60.
31. Tassone F., Hagerman R.J., Taylor A.K., Gane L.W., Godfrey T.E., Hagerman P.J. Elevated levels of FMR1 mRNA in carrier males. a new mechanism of involvement in the fragile-X syndrome Am. J. Hum. Genet. 66:2000;6-15.
32. Warrick J.M., Chan H.Y., Gray-Board G.L., Chai Y., Paulson H.L., Bonini N.M. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23:1999;425-428.
33. Warrick J.M., Paulson H.L., Gray-Board G.L., Bui Q.T., Fischbeck K.H., Pittman R.N., Bonini N.M. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell. 93:1998;939-949.
34. Willemsen R., Hoogeveen-Westerveld M., Reis S., Holstege J., Severijnen L.A., Nieuwenhuizen I.M., Schrier M., Van Unen L., Tassone F., Hoogeveen A.T.et al. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum. Mol. Genet. 12:2003;949-959.
35. Zhou H., Li S.H., Li X.J. Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation. J. Biol. Chem. 276:2001;48417-48424.
36. Zoghbi H.Y., Botas J. Mouse and fly models of neurodegeneration. Trends Genet. 18:2002;463-471.